Identification of Frailty in Chronic Heart Failure

Sze, Shirley and Pellicori, Pierpaolo and Zhang, Jufen and Weston, Joan and Clark, Andrew L. (2019) Identification of Frailty in Chronic Heart Failure. JACC: Heart Failure, 7 (4). pp. 291-302. ISSN 2213-1787

[img] Text
Accepted Version
Restricted to Repository staff only until 6 February 2020.
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (49kB) | Request a copy
[img] Text
Supplemental Material
Restricted to Repository staff only until 6 February 2020.
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (399kB) | Request a copy
Official URL: https://doi.org/10.1016/j.jchf.2018.11.017

Abstract

Objectives: This study sought to report the prevalence of frailty, classification performance, and agreement among 3 frailty assessment tools and 3 screening tools in chronic heart failure (CHF) patients. Background: Frailty is common in patients with CHF. There are many available frailty tools, but no standard method for evaluating frailty. Methods: We used the following frailty screening tools: the clinical frailty scale (CFS); the Derby frailty index; and the acute frailty network frailty criteria. We used the following frailty assessment tools: the Fried criteria; the Edmonton frailty score; and the Deficit Index. Results: A total of 467 consecutive ambulatory CHF patients (67% male; median age: 76 years; interquartile range [IQR]: 69 to 82 years; median N-terminal pro–B-type natriuretic peptide: 1,156 ng/l [IQR: 469 to 2,463 ng/l]) and 87 control patients (79% male; median age: 73 years (IQR: 69 to 77 years) were studied. The prevalence of frailty using the different tools was higher in CHF patients than in control patients (30% to 52% vs. 2% to 15%, respectively). Frail patients tended to be older, have worse symptoms, higher N-terminal pro–B-type natriuretic peptide levels, and more comorbidities. Of the screening tools, CFS had the strongest correlation and agreement with the assessment tools (correlation coefficient: 0.86 to 0.89, kappa coefficient: 0.65 to 0.72, depending on the frailty assessment tools, all p < 0.001). CFS had the highest sensitivity (87%) and specificity (89%) among screening tools and the lowest misclassification rate (12%) among all 6 frailty tools in identifying frailty according to the standard combined frailty index. Conclusions: Frailty is common in CHF patients and is associated with increasing age, comorbidities, and severity of heart failure. CFS is a simple screening tool that identifies a similar group using more lengthy assessment tools.

Item Type: Journal Article
Keywords: Heart failure, Frailty screening, Assessment
Faculty: Faculty of Health, Education, Medicine & Social Care
Depositing User: Jufen Zhang
Date Deposited: 31 Jan 2019 17:11
Last Modified: 14 Nov 2019 16:08
URI: http://arro.anglia.ac.uk/id/eprint/704073

Actions (login required)

Edit Item Edit Item